SOLVD Health, a patient intelligence company developing cutting-edge precision solutions to deliver better health outcomes, has published a peer-reviewed article in the International Journal of ...

For drug discovery and biomarker development, peptide-level validation strengthens confidence that selected targets represent ...

A recent study published in Molecular Psychiatry has successfully identified 11 independent genetic loci linked to delay discounting .Primarily, it scrutinized how these variants influence ...

Researchers have developed DrugtargetMR, a comprehensive computational tool designed to bridge the gap between genetic ...

Analyzing population-level chromatin accessibility data shows added benefit over utilizing only gene expression data in elucidating the genetic mechanism of disease-associated variants.

This first GWAS study in CPPD disease points to two targets for future treatment, which is crucial given the current lack of options for patients." Dr. Merriman concludes, "We are thrilled about the ...